CompoAtlas

Muscletech SX-7 Black Onyx #Shatter Neuro

Testo originale in francese.

Prodotto naturale per la salute autorizzato in Canada

Se questo prodotto fosse venduto in Francia

Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.

Composizione

Ingrediente medicinale e fontePer unità posologica, secondo la fonteMassimo giornaliero, adulto
Niacine

Fonte : Acide nicotinique

30 milligrammeNon calcolata
Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium

Fonte : N-acétyl L-chlorhydrate de carnitine

100 milligrammeNon calcolata
L-alpha-Glycérophosphorylcholine

Fonte : Alfoscérate de choline

75 milligrammeNon calcolata
Cytidine 5'-diphosphocholine

Fonte : Citicoline

50 milligrammeNon calcolata
N5-(Aminocarbonyl)-L-ornithine

Fonte : Citrulline

1,5 gNon calcolata
Citrus unshiu

Fonte : Fruit

2 milligrammeNon calcolata
Acide 3-aminopropionique

Fonte : Beta-alanine

1,6 gNon calcolata
1,3,7-triméthylxanthine

Fonte : Caféine

150 milligrammeNon calcolata
Myristica fragrans

Fonte : Graine(s)

Estratto : Matériel brut sec

Rapporto di estrazione : 5:1

Equivalente di pianta secca : 500 milligramme

100 milligrammeNon calcolata
Vitamine C

Fonte : Acide ascorbique

30 milligrammeNon calcolata
2-hydroxy-N,N,N-triméthyléthanaminium

Fonte : Bitartrate de choline

79,5 milligrammeNon calcolata
Scutellaria lateriflora

Fonte : Sommité

37,5 milligrammeNon calcolata
[5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one

Fonte : Huperzia serrata - plante entière

10 microgrammesNon calcolata
[5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one

Fonte : Huperzine A

10 microgrammesNon calcolata

Ingredienti non medicinali

Silice, Acide DL-malique, Saveur de melon d'eau, Acésulfame potassium, Sucralose, Acide citrique, Saveur de fraise, Rouge FD&C N° 40

Dosi raccomandate in Canada

PopolazioneEtàQuantità per assunzioneFrequenza
AdultesNon préciséeminimum : 1 Mesures ; maximum : 2 Mesures1 jour

Usi autorizzati in Canada

Helps (temporarily) to promote alertness and wakefulness and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance and to enhance motor performance. Helps to increase plasma L-arginine level, a precursor of nitric oxide. Helps to delay muscle fatigue by increasing carnosine levels. Workout Supplement. Athletic Support. Helps the body to metabolize carbohydrates, fats, and proteins. Source of antioxidants. Helps normal growth and development.

Testo originale in inglese.

Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.

Avvertenze in Canada

Cautions and Warnings : Discontinue use and consult a health care practitioner if you experience unusual symptoms. Consult a health care practitioner before use if you have been treated for, diagnosed with or have a family history of any medical condition, or if you are using any prescription or over-the-counter drug(s), including blood thinners. If you are taking any heart or blood pressure medication, consult a health care practitioner prior to use. If you have a heart condition or diabetes, consult a health care practitioner prior to use. If you are taking prescription medications, consult a health care practitioner prior to use. Do not exceed recommended serving. Improper use of this product will not improve results and is not advised. Use only as directed. Keep out of reach of children. If you are pregnant or breastfeeding or if you are attempting to conceive, do not use this product. Ensure to adequately hydrate before, during, and after exercise. Consult a health care practitioner prior to use if you are taking lithium. Do not use if you have cardiovascular disease risk factors (e.g. high blood pressure, high cholesterol and/or triglycerides, obesity) or glaucoma. Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. Hypersensitivity/allergy is known to occur, in which case, discontinue use. Consult a health care practitioner prior to use if you have detrusor instability (overactive bladder syndrome). Anxiety, tachycardia (rapid heart rate), palpitations, insomnia, restlessness, nervousness, tremor and headache may occur; in which case discontinue use and consult a health care practitioner. Caffeine has been shown to reduce blood flow to the heart muscle during exercise which might lead to cardiovascular complications such as chest pain, spasm and irregular heartbeat even in healthy individuals. If those symptoms occur discontinue use and consult a health care practitioner. May cause a flushing, tingling and/or prickling sensation of the skin, in which case, reduce the dose. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient. If you have liver disease, kidney disease and/or a seizure disorder, consult a health care practitioner prior to use. May cause digestive problems. Consumption with alcohol, other drugs and/or natural health products with sedative properties is not recommended. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. If you are taking anti-depressants, especially monoamine oxidase inhibitors (MAOIs) consult with a health care practitioner prior to use. If you suffer from heartburn or acid reflux, consult a health care practitioner prior to use. Discontinue use if you experience dizziness, sweating, muscle cramping/twitching, hyperactivity/anxiety or decreased appetite.

Testo originale in inglese.

Scheda del prodotto

Titolare
Iovate Health Sciences International Inc.
NPN o DIN-HM
80071923
Stato
Licenza attiva
Data della licenza
11 agosto 2016
Data di revisione
Non indicata
Forma
Poudre
Via di somministrazione
Orale
Tipo di domanda
Non traditionnelle

Fonte

Scheda ufficiale Health Canada, licenza 80071923

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Testo originale in inglese.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Testo originale in francese.

La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.

Avvertenze ufficiali (Health Canada)

Health Canada pubblica avvertenze su questi ingredienti:

  • Scutellaria lateriflora
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    SKULLCAP - SCUTELLARIA LATERIFLORA

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Bradley 2006; Tilgner 1999; Williamson et al. 1988; Ellingwood 1983; Felter and Lloyd 1983).

    Fonti citate da Health Canada (5)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
    • Ellingwood F. American Materia Medica, Therapeutics and Pharmacognosy. Sandy (OR): Eclectic Medical Publications; 1983 [Reprint of 1919 original].
    • Felter HW, Lloyd JU. King's American Dispensatory, Volume 1, 18th edition. Sandy (OR): Eclectic Medical Publications; 1983 [Reprint of 1898 original].
    • Tilgner S. Herbal Medicine from the Heart of the Earth. Creswell (OR): Wise Acre Press; 1999.
    • Williamson EM, Evans FJ, Wren RC. Potter's New Cyclopaedia of Botanical Drugs and Preparations. Saffron Walden (UK): C.W. Daniel Company Limited; 1988.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Controindicazioni

    Do not use if you are pregnant or breastfeeding (Barnes et al. 2007; Boon and Smith 2004).

    Fonti citate da Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.

    Monografia di Health Canada del 29 novembre 2024

Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.

La data della prova di questo elenco di ingredienti è sconosciuta.

Il prodotto è cambiato? Fotografi la confezione.

Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.

Invio per analizzare, Maiusc+Invio per una nuova riga